PEDIATRICS Vol. 54 No. 3 September 1974, pp. 358-360
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rucker, R. W.
Right arrow Articles by Harrison, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rucker, R. W.
Right arrow Articles by Harrison, G. M.

Outpatient Intravenous Medications in the Management of Cystic Fibrosis

Ralph W. Rucker M.D.1 and Gunyon M. Harrison M.D.1

1 Texas Institute for Rehabilitation and Research Houston, Texas

The use of an indwelling intravenous infusion set for the home administration of potent antibiotics has been quite successful in the therapy of the chronic bronchopulmonary infection associated with cystic fibrosis. Gentamicin and colistimethate have been used extensively for sensitive strains of mucoid and nonmucoid Pseudomonas organisms. The convenience, patient acceptability, lack of complications, prevention of hospitalizations and effectiveness entitles this mode of therapy to a place of importance in the management of this complication of cystic fibrosis.




This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. Gilchrist, B. D. Franklin, and J. P. Patel
An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service
J. Antimicrob. Chemother., July 1, 2008; 62(1): 177 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Jacqueline, J. Caillon, O. Grossi, V. Le Mabecque, A.-F. Miegeville, D. Bugnon, E. Batard, and G. Potel
In Vitro and In Vivo Assessment of Linezolid Combined with Ertapenem: a Highly Synergistic Combination against Methicillin-Resistant Staphylococcus aureus.
Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2547 - 2549.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
H. W. Kelly and C. Lovato
Antibiotic Use in Cystic Fibrosis
Ann. Pharmacother., July 1, 2006; 40(7): 1424 - 1435.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. Nathwani and A. Tice
Ambulatory antimicrobial use: the value of an outcomes registry
J. Antimicrob. Chemother., January 1, 2002; 49(1): 149 - 154.
[Abstract] [Full Text] [PDF]